Compass Pathways Phase II Results: A Disappointment For Some, An Opportunity For Others
November 11, 2021 at 16:51 PM EST
Compass Pathways reported "successful" but underwhelming results for its Phase IIb clinical trial using psilocybin to treat Treatment Resistant Depression. We identify the winners and losers from this news.
